Back to Search
GEOFFREY MILLS, M.D.
M.D.
Oral and Maxillofacial Surgery (Dentist)
NPI: 1760521850IndividualAccepts Medicare
Specialties, Licenses & Credentials
Oral & Maxillofacial Surgery (D.M.D.)
Oral & Maxillofacial Surgery
Code: 204E00000X
43017(KY)
Oral and Maxillofacial Surgery (Dentist)Primary
Dentist — Oral and Maxillofacial Surgery
Code: 1223S0112X
8703(KY)
CMS Specialties
PrimaryMAXILLOFACIAL SURGERY
Education
UNIVERSITY OF LOUISVILLE SCHOOL OF DENTISTRY
Class of 2007
Research & Publications (20)
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).
PMID 19557750·Head Neck·2010
3-trial
Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
PMID 19383058·Intern Med J·2010
4-observational
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
PMID 19573809·Cancer Cell·2009
8-other
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
PMID 19602588·Cancer Res·2009
7-preclinical
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
PMID 19470724·Clin Cancer Res·2009
8-other
Measurement of numicro and nue events in an off-axis horn-focused neutrino beam.
PMID 19519094·Phys Rev Lett·2009
8-other
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
PMID 19491266·Cancer Res·2009
7-preclinical
Genomic amplicons target vesicle recycling in breast cancer.
PMID 19620778·J Clin Invest·2009
7-preclinical
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.
PMID 19477432·Cancer Cell·2009
7-preclinical
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
PMID 19435916·Cancer Res·2009
8-other
The biology of ovarian cancer: new opportunities for translation.
PMID 19461667·Nat Rev Cancer·2009
6-review
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
PMID 19451593·Clin Cancer Res·2009
7-preclinical
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
PMID 19440550·PLoS One·2009
8-other
Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
PMID 19609003·Mol Cancer Res·2009
8-other
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
PMID 19435893·Cancer Res·2009
8-other
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.
PMID 19417153·Mol Cancer Ther·2009
8-other
PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
PMID 19395652·Am J Pathol·2009
7-preclinical
Current good manufacturing practices for PET drug products in the United States.
PMID 19652213·J Nucl Med·2009
8-other
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
PMID 19648920·Nat Genet·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 225 ABRAHAM FLEXNER WAY, SUITE 302
LOUISVILLE, KY 40202 - Phone
- (502) 587-7874
Quick Facts
- NPI
- 1760521850
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile